• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Biogen Idec Inc

+ Add to Watchlist

BIIB:US

311.410 USD 4.700 1.53%

As of 20:10:00 ET on 10/20/2014.

Snapshot for Biogen Idec Inc (BIIB)

Open: 305.240 Day's Range: 305.240 - 321.480 Volume: 1,513,757
Previous Close: 306.710 52wk Range: 230.250 - 358.890 1-Yr Rtn: +27.16%

Stock Chart for BIIB

No chart data available.
  • BIIB:US 311.519
  • 1D
  • 1M
  • 1Y
306.710
Interactive BIIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIIB

Current P/E Ratio (ttm) 35.0680
Estimated P/E(12/2014) 23.7084
Relative P/E vs. SPX 2.0561
Earnings Per Share (USD) (ttm) 8.8802
Est. EPS (USD) (12/2014) 13.1350
Est. PEG Ratio 1.2910
Market Cap (M USD) 73,537.82
Shares Outstanding (M) 236.14
30 Day Average Volume 1,236,208
Price/Book (mrq) 7.6912
Price/Sale (ttm) 8.8328
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIIB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BIIB

Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.

George A ScangosChief Executive OfficerSusan H AlexanderExec VP/Chief Legal Ofcr/Secy
Paul J ClancyExec VP:Finance/CFOAdriana Karaboutis "Andi"Exec VP:Tech & Bus Solutions
More Company Profile & Key Executives for BIIB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil